Dementia Care Partner Hospital Assessment Tool
University of Wisconsin, Madison · with National Institute on Aging (NIA) · NCT05592366
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 128
- US sites recruiting
- 1
- Study start
- April 2, 2024
- Record last updated
- August 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.
Being studied: Care Partner Hospital Assessment Tool
Conditions: Alzheimer Disease; Dementia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Provide unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of ADRD
- 18 years or older
Exclusion Criteria
- Non-English speaking
Recruiting US locations
University of Wisconsin
Madison, WI 53705
Site contact: Anne Mortensen · 608-262-2712 · amortensen3@wisc.edu
Study contacts (from the official record)
- Anne Mortensen · 608-262-2712 · amortensen3@wisc.edu
Similar studies in Wisconsin
All neurology studies in Wisconsin →- RecruitingHealthy volunteersPhase 1
The Gut - PRO Study
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Milwaukee, WI + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Greenfield, WI + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Milwaukee, WI + 18 other US sites
- Eligibility basics
- Ages 18–60